Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 9,514 shares at $82.48 ($785K) on 2026-01-20, disclosed to the SEC on 2026-01-21.
Seasonal sale ($785k) by Chief Medical Officer — this insider has traded PTGX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |
| PTGX | SELL | 2025-03-14 | $3.4M | — | Filing → |